JP2011524363A5 - - Google Patents

Download PDF

Info

Publication number
JP2011524363A5
JP2011524363A5 JP2011513686A JP2011513686A JP2011524363A5 JP 2011524363 A5 JP2011524363 A5 JP 2011524363A5 JP 2011513686 A JP2011513686 A JP 2011513686A JP 2011513686 A JP2011513686 A JP 2011513686A JP 2011524363 A5 JP2011524363 A5 JP 2011524363A5
Authority
JP
Japan
Prior art keywords
amine
methylamino
pyrimidin
pyrrolidin
pyridin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011513686A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011524363A (ja
JP5658662B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2009/047033 external-priority patent/WO2009152325A1/en
Publication of JP2011524363A publication Critical patent/JP2011524363A/ja
Publication of JP2011524363A5 publication Critical patent/JP2011524363A5/ja
Application granted granted Critical
Publication of JP5658662B2 publication Critical patent/JP5658662B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011513686A 2008-06-12 2009-06-11 ヒスタミンh4受容体のジアミノピリジン、ピリミジン、及びピリダジンモジュレーター Expired - Fee Related JP5658662B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US6103908P 2008-06-12 2008-06-12
US61/061,039 2008-06-12
US11442508P 2008-11-13 2008-11-13
US11441608P 2008-11-13 2008-11-13
US61/114,416 2008-11-13
US61/114,425 2008-11-13
PCT/US2009/047033 WO2009152325A1 (en) 2008-06-12 2009-06-11 Diamino-pyridine, pyrimidine, and pyridazine modulators of the histamine h4 receptor

Publications (3)

Publication Number Publication Date
JP2011524363A JP2011524363A (ja) 2011-09-01
JP2011524363A5 true JP2011524363A5 (https=) 2012-07-26
JP5658662B2 JP5658662B2 (ja) 2015-01-28

Family

ID=41417123

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011513686A Expired - Fee Related JP5658662B2 (ja) 2008-06-12 2009-06-11 ヒスタミンh4受容体のジアミノピリジン、ピリミジン、及びピリダジンモジュレーター

Country Status (20)

Country Link
US (3) US8841287B2 (https=)
EP (1) EP2315521B1 (https=)
JP (1) JP5658662B2 (https=)
KR (1) KR101600278B1 (https=)
CN (1) CN102118969B (https=)
AU (1) AU2009257434B2 (https=)
BR (1) BRPI0915720A2 (https=)
CA (1) CA2727684C (https=)
CO (1) CO6321192A2 (https=)
CR (1) CR20110029A (https=)
EA (1) EA018198B1 (https=)
EC (1) ECSP10010675A (https=)
IL (1) IL209593A (https=)
MX (1) MX2010013726A (https=)
MY (1) MY158927A (https=)
NI (1) NI201000214A (https=)
NZ (1) NZ589532A (https=)
PE (1) PE20110061A1 (https=)
WO (1) WO2009152325A1 (https=)
ZA (1) ZA201100298B (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007117399A2 (en) 2006-03-31 2007-10-18 Janssen Pharmaceutica N.V. Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine h4 receptor
BRPI0915720A2 (pt) 2008-06-12 2015-08-04 Janssen Pharmaceutica Nv Moduladores de diaminopiridina, pirimidina, e piridazina do receptor de histamina h4
BRPI0915526A2 (pt) * 2008-06-12 2016-01-26 Janssen Pharmaceutica Nv uso de um antagonista da histamina h4 para o tratamento de aderências pós-operatórias
US9371311B2 (en) 2008-06-30 2016-06-21 Janssen Pharmaceutica Nv Benzoimidazol-2-yl pyrimidine derivatives
CN102438993A (zh) * 2009-05-19 2012-05-02 陶氏益农公司 用于控制真菌的化合物和方法
WO2011078143A1 (ja) * 2009-12-22 2011-06-30 塩野義製薬株式会社 ピリミジン誘導体およびそれらを含有する医薬組成物
RU2014150494A (ru) * 2012-05-30 2016-07-20 Ф. Хоффманн-Ля Рош Аг Пирролидиногетероциклы
PT2964229T (pt) 2013-03-06 2020-03-23 Janssen Pharmaceutica Nv Moduladores de piridina benzimidazol-2-ilo do recetor h4 de histamina
WO2014147586A1 (en) * 2013-03-22 2014-09-25 Novartis Ag 1-(2-(ethylamino)pyrimidin-4-yl)pyrrolidin-2-ones as inhibitors of mutant idh
EP3055301B1 (en) * 2013-10-07 2019-11-20 Kadmon Corporation, LLC (2-(5-isoindolin-2-yl)pyrimidin-4-yl)-amine derivatives as rho kinase inhibitors for treating autoimmune diseases
ES2741831T3 (es) 2014-07-31 2020-02-12 Basf Se Proceso para la preparación de pirazoles
KR102585412B1 (ko) 2015-05-11 2023-10-05 바스프 에스이 4-아미노-피리다진의 제조 방법
WO2018071687A1 (en) * 2016-10-13 2018-04-19 The Regents Of The University Of California Methods of treating pruritis
WO2018082964A1 (en) 2016-11-04 2018-05-11 Basf Se Process for the production of pyridazinyl-amides in a one-pot synthesis
JP2022165429A (ja) * 2019-10-02 2022-11-01 Meiji Seikaファルマ株式会社 ヒスタミンh4受容体調節作用を有する新規トリアジン誘導体
MX2024000273A (es) * 2021-07-01 2024-01-31 Aerie Pharmaceuticals Inc Azetidinil pirimidinas y usos de las mismas.
CN116354937B (zh) * 2021-12-27 2025-07-11 江苏恩华药业股份有限公司 吡啶(嘧啶)胺类衍生物及其应用
CA3260763A1 (en) * 2022-06-29 2024-01-04 Alcon Inc. AZETIDINYL PYRIMIDINES AND THEIR USES AS JAK INHIBITORS

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759371A (fr) 1969-11-24 1971-05-24 Bristol Myers Co Azaspirodecanediones heterocycliques et procedes pour leur preparation
GB8609630D0 (en) 1986-04-19 1986-05-21 Pfizer Ltd Anti-arrhythmia agents
HU206337B (en) 1988-12-29 1992-10-28 Mitsui Petrochemical Ind Process for producing pyrimidine derivatives and pharmaceutical compositions
HK1002235A1 (en) 1989-12-28 1998-08-07 Pharmacia & Upjohn Company Diaromatic substituted anti-aids compounds
US5449676A (en) * 1991-04-26 1995-09-12 Byk Gulden Lomberg Chemische Fabrik Gmbh Pyridazines
CA2346659A1 (en) * 1998-10-06 2000-04-13 Michiyo Gyoten Condensed pyridazine compounds, their production and use
CA2394727A1 (en) 1999-12-28 2001-07-05 Pharmacopeia, Inc. Pyrimidine and triazine kinase inhibitors
EP1317450B1 (en) 2000-09-15 2006-11-22 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
SE0004245D0 (sv) 2000-11-20 2000-11-20 Pharmacia Ab Novel compounds and their use
WO2002072548A2 (en) 2001-03-09 2002-09-19 Ortho-Mcneil Pharmaceutical, Inc. Heterocyclic compounds and their use as histamine h4 ligands.
US6825198B2 (en) 2001-06-21 2004-11-30 Pfizer Inc 5-HT receptor ligands and uses thereof
MXPA04004178A (es) * 2001-11-01 2004-09-06 Janssen Pharmaceutica Nv Heteroarilaminas como inhibidores de glucogeno cintasa cinasa 3beta.
EP1485378B1 (en) 2002-03-13 2008-06-18 Janssen Pharmaceutica N.V. Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
DE60326436D1 (en) 2002-03-13 2009-04-16 Janssen Pharmaceutica Nv Aminoderivate als histone-deacetylase-inhibitoren
KR20040093692A (ko) * 2002-03-13 2004-11-08 얀센 파마슈티카 엔.브이. 히스톤 디아세틸라제의 신규한 저해제로서의 피페라지닐-,피페리디닐- 및 모르폴리닐-유도체
WO2004052862A1 (ja) 2002-12-10 2004-06-24 Ono Pharmaceutical Co., Ltd. 含窒素複素環化合物およびその医薬用途
EP1437348A1 (fr) 2003-01-13 2004-07-14 L'oreal Dérivés de de la 6-méthyl-pyrimidine-2,4-diamine, procédé de synthèse, compositions les comprenant et utilisations comme agents neutralisants basiques
EP1505064A1 (en) 2003-08-05 2005-02-09 Bayer HealthCare AG 2-Aminopyrimidine derivatives
WO2005054239A1 (en) * 2003-12-05 2005-06-16 Bayer Healthcare Ag 2-aminopyrimidine derivatives
JP2007522233A (ja) * 2004-02-11 2007-08-09 アムジエン・インコーポレーテツド バニロイド受容体リガンド及び治療におけるそれらの使用
AU2005303893A1 (en) 2004-11-11 2006-05-18 Argenta Discovery Ltd Pyrimidine compounds as histamine modulators
JP2008524131A (ja) 2004-12-16 2008-07-10 エフ.ホフマン−ラ ロシュ アーゲー 抗肥満薬としてのピペラジニルピリジン誘導体
US20090306038A1 (en) * 2005-09-13 2009-12-10 Carceller Gonzalez Elena 2-Aminopyrimidine derivatives as modulators of the histamine H4 receptor activity
EP1767537A1 (en) 2005-09-21 2007-03-28 Cellzome (UK) Ltd. Pyrimidine compounds for the treatment of inflammatory disorders
NL2000323C2 (nl) 2005-12-20 2007-11-20 Pfizer Ltd Pyrimidine-derivaten.
SI1981874T1 (sl) 2006-01-19 2009-10-31 Janssen Pharmaceutica Nv Aminofenilni derivati kot novi inhibitorji histon deacetilaze
EP1829879A1 (en) 2006-02-10 2007-09-05 Cellzome (UK) Ltd. Amino pyrimidine compounds for the treatment of inflammatory disorders
WO2007090854A1 (en) 2006-02-10 2007-08-16 Cellzome (Uk) Ltd. Azetidine amino pyrimidine compounds for the treatment of inflammatory disorders
WO2007090853A1 (en) 2006-02-10 2007-08-16 Cellzome (Uk) Ltd. Enantiomers of amino pyrimidine compounds for the treatment of inflammatory disorders
WO2007117399A2 (en) 2006-03-31 2007-10-18 Janssen Pharmaceutica N.V. Benzoimidazol-2-yl pyrimidines and pyrazines as modulators of the histamine h4 receptor
GB0610909D0 (en) * 2006-06-05 2006-07-12 Merck Sharp & Dohme Therapeutic treatment
WO2008031556A2 (en) * 2006-09-12 2008-03-20 Ucb Pharma, S.A. 2 amino-pyrimidine derivatives as h4 receptor antagonists, processes for preparing them and their use in pharmaceutical compositions
EP1920654A1 (en) 2006-09-13 2008-05-14 Syngeta Participations AG Novel pyridopyrazine N-oxides
US7985745B2 (en) 2006-10-02 2011-07-26 Abbott Laboratories Method for pain treatment
WO2008074445A1 (en) 2006-12-18 2008-06-26 Ucb Pharma, S.A. Novel tricyclic and heterotricyclic derivatives, processes for preparing them, pharmaceutical compositions thereof
CL2008000467A1 (es) 2007-02-14 2008-08-22 Janssen Pharmaceutica Nv Compuestos derivados de 2-aminopirimidina, moduladores del receptor histamina h4; su procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar un trastorno inflamatorio seleccionado de alegia, asma
EP2144877A1 (en) 2007-04-04 2010-01-20 UCB Pharma, S.A. Novel pyridine derivatives, processes for preparing them, pharmaceutical compositions thereof
WO2009068512A1 (en) 2007-11-30 2009-06-04 Palau Pharma, S. A. 2 -amino-pyrimidine derivatives as histamine h4 antagonists
AR072084A1 (es) 2008-06-12 2010-08-04 Sanofi Aventis Derivados de azacarbolinas, su preparacion y su utilizacion terapeutica como inhibidores de las quinasas pim
BRPI0915720A2 (pt) 2008-06-12 2015-08-04 Janssen Pharmaceutica Nv Moduladores de diaminopiridina, pirimidina, e piridazina do receptor de histamina h4
SI2356123T1 (sl) 2008-11-13 2013-01-31 F. Hoffmann-La Roche Ag Piro-5,6-dihidro-4h-2,3,5,10b-tetraaza-benzo(e)azuleni
JO2870B1 (en) 2008-11-13 2015-03-15 ميرك شارب اند دوهم كورب Amino Tetra Hydro Pirans as Inhibitors of Peptide Dipeptide IV for the Treatment or Prevention of Diabetes

Similar Documents

Publication Publication Date Title
JP2011524363A5 (https=)
US11878975B2 (en) Substituted indole compounds useful as TLR inhibitors
JP5658662B2 (ja) ヒスタミンh4受容体のジアミノピリジン、ピリミジン、及びピリダジンモジュレーター
JP6218260B2 (ja) Jak阻害剤としてのアミノピリミジニル化合物
RU2345996C1 (ru) Аннелированные азагетероциклические амиды, включающие пиримидиновый фрагмент, способ их получения и применения
JP5394404B2 (ja) キナーゼ阻害剤として有用な置換イミダゾピリダジン類
CN111372931B (zh) 作为蛋白激酶抑制剂的杂环化合物
JP2021138718A (ja) 統合ストレス経路のモジュレーター
CN120712271A (zh) 作为kras g12d抑制剂的新型三环化合物及其用途
JP6585158B2 (ja) ヤヌスキナーゼの阻害に有用なピロロ[2,3−d]ピリミジン誘導体
JP2017524007A5 (https=)
BR112020008839A2 (pt) moduladores da via de estresse integrada
JP2009522206A5 (https=)
JP2020510010A5 (https=)
JP2014503566A5 (https=)
CN107667092B (zh) 作为fgfr4抑制剂的甲酰化n-杂环衍生物
JP2009513575A5 (https=)
JP2009542638A5 (https=)
TW201225957A (en) Glycine transporter inhibitor
JP2007517904A5 (https=)
JP2012502975A5 (https=)
CN101969951A (zh) 治疗关节炎的方法
CA2568608A1 (en) Six membered amino-amide derivatives as angiogenesis inhibitors
JP2017535536A (ja) カルバゾール誘導体
RU2013142881A (ru) Имидазопиразины